Company Overview

Development Stage

About the Company

[Summary] 聚合生命能量,呵护人类健康

浙江司太立制药股份有限公司成立于1997年,是一家专业从事研发、生产、销售X-CT非离子型碘造影剂系列和喹诺酮类系列原料药及中间体的*高新技术企业。
  公司是国内X射线造影剂原料药产品线*丰富的公司之一,已具备产业化能力的产品有碘海醇原料药、碘帕醇原料药、碘佛醇原料药、碘普罗胺原料药、碘克沙醇原料药等。其中,碘海醇原料药产能及产量位居国内首位,是国内X-CT非离子型造影剂原料药龙头企业。公司产品质量稳定,并取得多个发达国家认证。目前,获得欧盟CEP证书全球碘海醇原料药生产厂家有4家,中国仅司太立*一家;获得日本登录证的全球碘海醇原料药生产厂家有4家,司太立亦是其中之一。
  在喹诺酮类系列原料药方面,公司在左氧氟沙星系列产品杂质分离及合成领域处于*水平。2012年,公司生产规模列全国第四位,是国内产量*大的左氧氟沙星系列生产企业之一。
  公司长期着眼于X射线造影剂的可持续发展战略,高度重视自主研发能力,并取得了丰硕的成果。公司建有浙江省司太立诊断药物研究院、浙江省企业技术中心以及省级高新技术研究开发中心。公司承担的“非离子型X-CT造影剂原料药—碘海醇”项目和“第四代喹诺酮类抗菌药物关键中间体帕珠沙星产业化”项目均获得了由中华人民共和国科学技术部火炬高技术产业开发中心颁发的“国家火炬计划项目证书”。碘海醇和帕珠沙星还被浙江省科学技术厅评定为“浙江省高新技术产品”。“高纯度非离子型X-CT造影剂—碘海醇的合成工艺开发及产业化”项目被浙江省人民政府和台州市人民政府分别评为“浙江省科学技术二等奖”和“台州市科学技术进步一等奖”。
  司太立以“聚合生命能量,呵护人类健康”为经营理念,以“专造替代进口,填补国内空白”为发展方针,不断丰富X射线造影剂系列产品,力求将现有X射线造影剂原料药核心产品做到规模*大。同时致力于研制具有自主知识产权的新药,加快向制剂领域发展。公司将力争成为中国乃至全球的知名医药企业,铸就卓越的“司太立”医药品牌。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

司太立 Financing History (1 rounds)

Manage
IPO上市
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Market: 主板
  • Deal: 上交所

司太立 How Fast Is Hiring Growing? (3 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 166%
  • 2024: Down 60%
  • 2023: Up 65%
  • 2022: Flat 0%-
司太立 Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 浙江司太立制药股份有限公司 growing? 司太立2025: 133 openings (up 166%), 2024: 50 openings (down 60%), 2023: 124 openings (up 65%), 2022: 75 openings (flat), 2021: 75 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

司太立 Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
司太立 Master's Hiring by Year: 2024 — 8 fewer jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 浙江司太立制药股份有限公司 growing? 司太立Master's recruitment over the years: 2024: 2 openings (down 60%), 2023: 10 openings (up 65%), 2022: 6 openings (flat), 2021: 3 openings.

司太立 Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
司太立 Doctoral Hiring by Year: 2024 — same as 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 浙江司太立制药股份有限公司 growing? 司太立Doctorate recruitment over the years: 2024: 1 openings (down 60%), 2023: 1 openings (up 65%), 2022: 1 openings (flat), 2021: 1 openings.

司太立 — What Are the Salaries Like? (71 records)

Manage
司太立 Salary Overview
salary range: 4.5K - 50K, 50.7% of roles pay ¥4.5-8K
Note: salary statistics are based on 71 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 浙江司太立制药股份有限公司?司太立50.7% of positions earn 4.5-8K, Undergraduate salary: ¥。Taizhou salary ranking top 20,经营管理类 average salary ¥25.9K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 司太立

(More)
Are salaries high at 浙江司太立制药股份有限公司? We provide: qa,qc,仪表,分析,副主任,生产总监,人事,招聘专员,操作工,检测,质量,人力,人资,仓储副经理,实验员,维修工,设备员,设备维修,部长,采购. Click to view detailed salary analysis by job.

司太立 — Fortune 500? (More)

Yes, ranked in 中国新经济500强:

Yes, ranked in 中国企业慈善公益500强:

司太立 honors, qualifications & industry associations

司太立 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 经营管理类
    40.8% of total 40.8%
  • 工厂生产类
    38% of total 38%
  • 质量管理类
    26.8% of total 26.8%
  • 技工类
    19.7% of total 19.7%

Education

  • 本科
    88.7% of total 88.7%
  • 高中
    5.6% of total 5.6%
  • 大专
    5.6% of total 5.6%

Experience

  • 不限
    69% of total 69%
  • 5-10年
    16.9% of total 16.9%
  • 1-3年
    9.9% of total 9.9%
  • 3-5年
    4.2% of total 4.2%
View Detailed Analysis

What does 浙江司太立制药股份有限公司 require? Who is 司太立 hiring? 司太立 recruitment: 经营管理类占比最多占40.8%,其次是工厂生产类占38%. What education can get in at 司太立? 本科占比最多占88.7%,其次是高中占5.6%. Work experience required at 司太立? 不限占比最多占69%,其次是5-10年占16.9%. Where are the job locations at 司太立? 台州占比最多占85.9%,其次是宜春占14.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 43,840.9881万(元)
Legal Representative: 胡健
Date Established:
Credit Code: 91330000704720655L
Registered Address: 浙江省仙居县现代工业集聚区司太立大道1号

Partners & Suppliers

上海司太立制药有限公司向浙江司太立制药股份有限公司采购造影剂原料药(如碘海醇、碘克沙醇等) Source
合作客户 原料药供应
V
瑞华制药为司太立提供造影剂原料药研发服务 Source
供应商 原料药及中间体CDMO
江西司太立从母公司浙江司太立采购生产造影剂原料药所需的中间体或关键物料 Source
合作客户 化工中间体供应商
江西司太立生产的造影剂原料药主要销售给母公司浙江司太立,用于进一步加工或销售 Source
供应商 造影剂原料药客户
意大利博莱科集团在华子公司,司太立为其供应造影剂原料药 Source
合作客户 造影剂制剂(国外客户)

People who follow 司太立 also follow

司太立 Competitors (Similar Companies)

“氟喹诺酮原料药主要生产基地”
制药/药业 医药 抗生素 医药制造
制药/药业 医药 医药中间体 造影剂
“直接接触各类注射剂类药物包装的研发制造和销售”
“Provides consulting and services to over one hundred pharmaceutical ma”
“日出实业集团有限公司是一家集生产、研发、国际贸易为一体的综合性化工集团企业。”
“Steroid APIs and preparations. Produce first-class products, committed”
汽车减振器 汽车减震器 活塞杆 活塞
电子设备 电子厂/电子 转换器 电源转换
“Mainly engaged in the R&D, production, and sales of intelligent equipm”
“Providing high-quality, efficient, and individualized solutions for gl”
制药/药业 医药 医药中间体 抗肿瘤药
“率先实现了聚乳酸树脂的国产化”
电机 压缩机 制冷 制冷设备
节能减排 外墙外保温 保温板 保温管

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates